Benjamin K. Chen, MD, PhD, discussed the next steps after the results of his study in genetic tagging showed promise in ...

The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval ...

A study published last week suggests that, if vaccine uptake continues to decline, measles will soon be endemic again in the ...

HF2446 : The Minnesota House passed the agriculture Budget bill, 130-3, increasing total funding for Agriculture by $17 ...

Some of Kennedy’s allies say he’s become almost inaccessible since his confirmation and complain that he’s made glacial progress advancing MAHA goals, such as halting mRNA-based COVID shots and ...

Japan biopharmaceutical logistics market was valued at US$ 6.34 billion in 2024 and is expected to reach US$ 12.21 billion by 2033 at a CAGR of 7.77% during the forecast period 2025-2033.

What will the Trump administration’s proposed changes to federal science spending mean for biomedical research?

In a world obsessed with optimization, we are missing the real lever of progress. It is not just productivity, but creative endurance. The past few years have brought a tidal wave of apps, systems, ...

Among the major classes of RNAs in the cell, tRNAs remain the most difficult to characterize via deep sequencing approaches, as tRNA structure and nucleotide modifications can each interfere with cDNA ...

Lipid nanoparticle (LNP) mRNA vaccines emerged during the COVID-19 pandemic to form an almost miraculous protection against a virus, which killed millions around the world. Aided by expedited ...

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

“She’s an example of this emerging face of cancer that's really quite challenging and quite alarming,” Deignan said.